XML 61 R33.htm IDEA: XBRL DOCUMENT v3.25.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Dec. 31, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Cassie Jung [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Our Chief Operating Officer Cassie Jung adopted a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Jung Plan") on December 10, 2024. The Jung Plan commences on March 11, 2025 and ends on December 31, 2025. The maximum number of shares to be sold under the Jung Plan is 108,656 shares; the actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Jung Plan.
Name Cassie Jung  
Title Chief Operating Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 10, 2024  
Expiration Date December 31, 2025  
Arrangement Duration 386 days  
Aggregate Available 108,656 108,656
Carl Kraus [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Our Chief Medical Officer Carl Kraus adopted a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Kraus Plan") on December 12, 2024. The Kraus Plan commences on March 17, 2025 and ends on February 27, 2026. The maximum number of shares to be sold under the Kraus Plan is 75,000. The actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Kraus Plan.
Name Carl Kraus  
Title Chief Medical Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 12, 2024  
Expiration Date February 27, 2026  
Arrangement Duration 442 days  
Aggregate Available 75,000 75,000